Cite
HARVARD Citation
Grohe, C. et al. (n.d.). 66P Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455). Annals of oncology. p. . [Online].